Nemaura medical inc. (NMRD)
Income statement / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13
Revenue:
Total revenues

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

Operating expenses:
Research and development

2,336

2,263

2,423

2,296

1,775

1,687

1,274

993

953

866

877

1,034

981

960

1,070

1,028

1,109

1,005

926

824

686

717

486

383

0

0

0

General and administrative

2,719

2,666

2,536

2,180

1,644

1,276

989

915

746

733

596

516

627

603

560

511

548

482

527

495

259

410

307

202

0

0

0

Total operating expenses

5,056

4,929

4,959

4,476

3,420

2,963

2,263

1,908

1,700

1,599

1,474

1,551

1,609

1,563

1,630

1,539

1,657

1,487

1,453

1,319

946

1,127

793

586

0

0

0

Loss from operations

-5,056

-4,929

-4,959

-4,476

-3,420

-2,963

-2,263

-1,908

-1,700

-1,599

-1,474

-1,551

-1,609

-1,563

-1,630

-1,539

-1,657

-1,487

-1,453

-1,319

-946

-1,127

-793

-586

0

0

0

Interest income

3

10

19

23

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income tax benefit

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for income tax benefit

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-4,437

-4,918

-4,940

-4,452

-3,381

-2,922

-2,175

-1,820

-1,626

-1,535

-1,464

-1,551

-1,609

-1,563

-1,630

-1,539

-1,657

-1,487

-1,453

-1,319

-946

-1,127

-793

-586

0

0

0

Other comprehensive loss:
Foreign currency translation adjustment

-36

-49

-80

-299

-145

-70

127

564

423

-9

-28

-760

-677

-235

-382

135

26

5

21

28

35

-2

14

16

0

0

0

Comprehensive loss

-4,474

-4,967

-5,021

-4,752

-3,527

-2,992

-2,048

-1,255

-1,202

-1,544

-1,493

-2,312

-2,287

-1,798

-2,013

-1,403

-1,631

-1,482

-1,432

-1,291

-910

-1,129

-779

-570

0

0

0

Net loss per share, basic and diluted

-0.02

-0.01

-0.01

-0.01

-0.05

-0.01

-0.01

-

-

0.00

0.00

0.00

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

0.00

0.00

0.00

0.00

-

-

-

-

Earnings Per Share, Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.00

Weighted average number of common shares outstanding

20,808

208,021

207,836

207,561

20,540

205,003

105,821

68,870

121,411

205,000

205,000

208,273

205,000

205,000

201,726

205,001

201,902

200,000

200,000

200,000

200,000

200,000

200,000

181,260

180,000

180,000

200,000